Following a positive a positive European Medicines Agency recommendation in July, the European Commission (EC) has now ...

Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of ...

Johnson & Johnson has halted its plan to implement a 340B rebate model after the Health Resources and Services Administration ...

ARS Pharmaceuticals' Neffy, the first needle-free epinephrine nasal spray, is poised to significantly impact the treatment of ...

Recipharm and Exela Pharma Sciences have formed an exclusive strategic alliance to expand sterile manufacturing capabilities ...

Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the ...

Rivus Pharmaceuticals announced new Phase IIa HuMAIN study data for HU6, its investigational treatment for obesity-related ...

The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will ...

Family-controlled Italian drugmaker Chiesi Group yesterday celebrated the operational launch of its Biotech Center of ...

AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has ...

Kezar Life Sciences saw its share tumble more than 42% to 40.77 yesterday, after it revealed it was voluntarily pausing ...

Germany-headquartered CNS drug specialist Neuraxpharm Group today announced the launch of Neuraxpharm Middle East to cover ...